Glycemia and Its Relationship to Outcomes in the Metformin in Gestational Diabetes Trial
Open accessThe DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To determine how glucose control in women with GDM treated with metformin and/or insulin influenced pregnancy outcomes. RESEARCH DESIGN AND METHODS: Women randomly assigned to metformin or insulin treatment in the Metformin in Gestational Diabetes (MiG) trial had baseline glucose tolerance test (OGTT) results and A1C documented, together with all capillary glucose measurements during treatment. In the 724 women who had glucose data for analysis, tertiles of baseline glucose values and A1C and of mean capillary glucose values during treatment were calculated. The relationships between maternal factors, glucose values, and outcomes (including a composite of neonatal complications, preeclampsia, and large-for-gestational-age [LGA] and small-for-gestational-age infants) were examined with bivariable and multivariate models. RESULTS: Baseline OGTT did not predict outcomes, but A1C predicted LGA infants (P = 0.003). During treatment, fasting capillary glucose predicted neonatal complications (P < 0.001) and postprandial glucose predicted preeclampsia (P = 0.016) and LGA infants (P = 0.001). Obesity did not influence outcomes, and there was no interaction between glycemic control, randomized treatment, or maternal BMI in predicting outcomes. The lowest risk of complications was seen when fasting capillary glucose was <4.9 mmol/l (mean ± SD 4.6 ± 0.3 mmol/l) compared with 4.9–5.3 mmol/l or higher and when 2-h postprandial glucose was 5.9–6.4 mmol/l (6.2 ± 0.2 mmol/l) or lower. CONCLUSIONS: Glucose control in women with gestational diabetes mellitus treated with metformin and/or insulin is strongly related to outcomes. Obesity is not related to outcomes in this group. Targets for fasting and postprandial capillary glucose may need to be lower than currently recommended.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“which fits with other data showing that maternal glycemia relates to birth weight.21–23”
From Metformin in gestational diabetes: the offspring follow-up (MiG TOFU): body composition and metabolic outcomes at 7-9 years of age (2018) · cites this paper as [23]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hyperglycemia and adverse pregnancy outcomes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707943 · Cited by 5,563
Effect of Treatment of Gestational Diabetes Mellitus on Pregnancy Outcomes
Crowther, C. A., Hiller, J. E., Moss, J. R., McPhee, A. J., Jeffries, W. S., & Robinson, J. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042973 · Cited by 3,159
Metzger, B. E., Buchanan, T. A., Coustan, D. R., de Leiva, A., Dunger, D. B., Hadden, D. R., Hod, M., Kitzmiller, J. L., Kjos, S. L., Oats, J. N., et al. (2007) · Diabetes Care · doi:10.2337/dc07-s225 · Cited by 1,908
Preeclampsia: An excessive maternal inflammatory response to pregnancy
Redman, C. W. G., Sacks, G. P., & Sargent, I. L. (1999) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(99)70239-5 · Cited by 1,840
Ceriello, A., Esposito, K., Piconi, L., Ihnat, M. A., Thorpe, J. E., Testa, R., Boemi, M., & Giugliano, D. (2008) · Diabetes · doi:10.2337/db08-0063 · Cited by 1,310 · cited 1×
“A further study has shown that fluctuating glucose levels have a stronger effect on endothelial function (important in the pathogenesis of preeclampsia [14]) than sustained hyperglycemia (15).”
BackgroundMetformin versus insulin for the treatment of gestational diabetes
Rowan, J. A., Hague, W. M., Gao, W., Battin, M. R., & Moore, M. P. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707193 · Cited by 1,291 · cited 2×
“The methodology and outcomes have been published previously (10).”
MethodSelf-citationGestational diabetes: The consequences of not treating
Langer, O., Yogev, Y., Most, O., & Xenakis, E. M. J. (2005) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2004.11.039 · Cited by 677 · cited 1×
“A lthough treatment of gestational diabetes mellitus (GDM) has been shown to improve perinatal outcomes (1,2), there is lack of consensus about ideal glucose targets and how other factors, such as fetal abdominal circumference, should influence these targets (3,4).”
BackgroundHyperglycemia and Adverse Pregnancy Outcomes
Metzger, B. E., Lowe, L. P., Dyer, A. R., Trimble, E. R., Chaovarindr, U., Coustan, D. R., Hadden, D. R., McCance, D. R., Hod, M., McIntyre, H. D., et al. (2009) · Obstetric Anesthesia Digest · doi:10.1097/01.aoa.0000344706.95925.dc · Cited by 479
Langer, O., Levy, J., Brustman, L., Anyaegbunam, A., Merkatz, R., & Divon, M. (1989) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(89)90371-2 · Cited by 376 · cited 2×
“There was no increase in SGA infants in the lowest glucose tertile, but mean glucose values were above the threshold previously shown to increase risk of SGA infants (9).”
BackgroundOverweight and obese in gestational diabetes: The impact on pregnancy outcome
Langer, O., Yogev, Y., Xenakis, E. M. J., & Brustman, L. (2005) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2004.12.049 · Cited by 239 · cited 2×
“Obesity has been reported as an independent factor influencing outcome in women with GDM treated with diet but not in those treated with insulin (7,8).”
BackgroundResult
Cited by
Feig, D. S., Berger, H., Donovan, L., Godbout, A., Kader, T., Keely, E., & Sanghera, R. (2018) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.10.038 · Cited by 344
“Importantly, it has been demonstrated that the diagnostic OGTT values were not the best predictors of outcomes whereas CBG levels during treatment were strongly correlated to adverse pregnancy outcomes (325).”
BackgroundRowan, J. A., Rush, E. C., Plank, L. D., Lu, J., Obolonkin, V., Coat, S., & Hague, W. M. (2018) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2017-000456 · Cited by 305
Self-citationMetformin vs insulin in the management of gestational diabetes: a meta-analysis
Gui, J., Liu, Q., & Feng, L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064585 · Cited by 222
“In addition, there is an increased risk for neonatal death, still birth and congenital defects [5] resulting from excessive mother-to-fetus glucose transfer [6], [7].”
BackgroundTreatments for gestational diabetes
Alwan, N., Tuffnell, D. J., & West, J. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003395.pub2 · Cited by 214
Niromanesh, S., Alavi, A., Sharbaf, F. R., Amjadi, N., Moosavi, S., & Akbari, S. (2012) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.09.031 · Cited by 203
“[6] Rowan JA, Gao W, Hague WM, McIntyre HD.”
BackgroundInsulin for the treatment of women with gestational diabetes
Brown, J., Grzeskowiak, L., Williamson, K., Downie, M. R., & Crowther, C. A. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012037.pub2 · Cited by 158
Gestational Diabetes Mellitus and Preeclampsia: Correlation and Influencing Factors
Yang, Y., & Wu, N. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.831297 · Cited by 155
“In a randomized controlled trial in New Zealand/Australia, 724 multi-ethnic subjects were included, the risk of PE in Polynesian is twice that in European/Caucasian/mixed (57).”
BackgroundResultInfluentialMurphy, H. R., Steel, S. A., Roland, J. M., Morris, D., Ball, V., Campbell, P. J., Temple, R. C., & on behalf of East Anglia Study Group for Improving Pregnancy Outcomes in Women with Diabetes (EASIPOD) (2011) · Diabetic Medicine · doi:10.1111/j.1464-5491.2011.03333.x · Cited by 134
Ijäs, H., Vääräsmäki, M., Saarela, T., Keravuo, R., & Raudaskoski, T. (2015) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.12964 · Cited by 127
Diabetes in pregnancy: a new decade of challenges ahead
the Diabetic Pregnancy Study Group, Schaefer-Graf, U., Napoli, A., & Nolan, C. J. (2018) · Diabetologia · doi:10.1007/s00125-018-4545-y · Cited by 118
“Of note, glucose levels in healthy pregnant women are lower than recommended target levels in GDM guidelines [38], and both fasting and postprandial glucose levels in GDM adversely affect outcomes [39].”
BackgroundLapolla, A., Dalfrà, M. G., Ragazzi, E., De Cata, A. P., & Fedele, D. (2011) · Diabetic Medicine · doi:10.1111/j.1464-5491.2011.03351.x · Cited by 105
Diabetes gestacional: um algoritmo de tratamento multidisciplinar
Weinert, L. S., Silveiro, S. P., Oppermann, M. L. D. R., Salazar, C. C., Simionato, B. M., Siebeneichler, A., & Reichelt, A. J. (2011) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302011000700002 · Cited by 147
“A medida basal do teste A1c, ao diagnóstico do diabetes gestacional, está associada com o aumento da taxa de recém-nascidos grande para idade gestacional (38,40) e de pré-eclâmpsia (38).”
BackgroundIs There a Role for HbA1c in Pregnancy?
Hughes, R. C. E., Rowan, J., & Florkowski, C. M. (2016) · Current Diabetes Reports · doi:10.1007/s11892-015-0698-y · Cited by 127
Self-citationDiabetes in pregnancy outcomes: A systematic review and proposed codification of definitions
The International Association of Diabetes in Pregnancy Study Group (IADPSG) Working Group on Outcome Definitions, Feig, D. S., Corcoy, R., Jensen, D. M., Kautzky‐Willer, A., Nolan, C. J., Oats, J. J. N., Sacks, D. A., Caimari, F., & McIntyre, H. D. (2015) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2640 · Cited by 100
Metformin for gestational diabetes in routine clinical practice
Goh, J. E. L., Sadler, L., & Rowan, J. (2011) · Diabetic Medicine · doi:10.1111/j.1464-5491.2011.03361.x · Cited by 99
Self-citationCésar, M. J. P., Molina‐Vega, M., Suárez-Arana, M., González‐Mesa, E., Sola-Moyano, A. P., Roldan-López, R., Romero-Narbona, F., Olveira, G., Tinahones, F. J., & González‐Romero, S. (2021) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2021.04.229 · Cited by 111
Pertot, T., Molyneaux, L., Tan, K., Ross, G. P., Yue, D. K., & Wong, J. (2011) · Diabetes Care · doi:10.2337/dc11-0499 · Cited by 87
“2 mmol/L at 1 h and are standard practice at Royal Prince Alfred Hospital in keeping with previous studies (8,9).”
MethodGeraghty, A. A., Alberdi, G., O’Sullivan, E. J., O’Brien, E. C., Crosbie, B., Twomey, P. J., & McAuliffe, F. M. (2017) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-017-1543-x · Cited by 82
Controversies in gestational diabetes
Nolan, C. J. (2010) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2010.10.004 · Cited by 94
Metformin versus insulin for gestational diabetes: a systematic review and meta-analysis
Bao, L.-X., Shi, W., & Han, Y. (2019) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2019.1670804 · Cited by 82
Changing trends in management of gestational diabetes mellitus
Poomalar, G. K. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i2.284 · Cited by 68
The diagnosis of gestational diabetes mellitus: new paradigms or status quo?
The International Association of Diabetes & Pregnancy Study Groups (IADPSG) Consensus Panel Writing Group and the Hyperglycemia & Adverse Pregnancy Outcome (HAPO) Study Steering Committee (2012) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2012.718002 · Cited by 68
Pregnancy in polycystic ovary syndrome
Kamalanathan, S., Sahoo, J. P., & Sathyapalan, T. (2013) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.107830 · Cited by 79
Fetal overgrowth in women with type 1 and type 2 diabetes mellitus
Ladfors, L., Shaat, N., Wiberg, N., Katasarou, A., Berntorp, K., & Kristensen, K. (2017) · PLOS ONE · doi:10.1371/journal.pone.0187917 · Cited by 66
Metformin versus insulin for gestational diabetes mellitus: a meta-analysis
Zhao, L., Sheng, X., Zhou, S., Yang, T., Ma, L., Zhou, Y., & Cui, Y. (2015) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12672 · Cited by 63
“Discussion The Rowan 2010 [28] paper on the MiG trial found that glycemic control in women with GDM treated with metformin and/or insulin was strongly related to the following: HbA1c% predicted LGA infants (P = 0.”
BackgroundMethodInfluentialAsistencia a la gestante con diabetes. Guía de práctica clínica actualizada en 2014
Acosta, D., Balsells, M., Ballesteros, M., Bandrés, O., Bartha, J. L., Bellart, J., Chico, A. I., Codina, M., Corcoy, R., Cortázar, A., et al. (2015) · Avances en Diabetología · doi:10.1016/j.avdiab.2014.12.001 · Cited by 80
Metformin for the treatment of gestational diabetes: An updated meta-analysis
Kitwitee, P., Limwattananon, S., Limwattananon, C., Waleekachonlert, O., Ratanachotpanich, T., Phimphilai, M., Nguyen, T. V., & Pongchaiyakul, C. (2015) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2015.05.017 · Cited by 55
Parellada, C. B., Ásbjörnsdóttir, B., Ringholm, L., Damm, P., & Mathiesen, E. R. (2014) · Diabetic Medicine · doi:10.1111/dme.12558 · Cited by 57
Rowan, J. A., Budden, A., Ivanova, V., Hughes, R. C., & Sadler, L. C. (2016) · Diabetic Medicine · doi:10.1111/dme.12812 · Cited by 41
Self-citationThe emerging role of metformin in gestational diabetes mellitus
Gray, S. G., McGuire, T. M., Cohen, N., & Little, P. J. (2017) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12893 · Cited by 40
Preeclampsia: A comprehensive review
Ali, M., Ahmed, M., Memon, M., Chandio, F., Shaikh, Q., Parveen, A., & Phull, A. R. (2024) · Clinica Chimica Acta · doi:10.1016/j.cca.2024.119922 · Cited by 63
The maternal womb: a novel target for cancer prevention in the era of the obesity pandemic?
Simmen, F. A., & Simmen, R. C. M. (2011) · European Journal of Cancer Prevention · doi:10.1097/cej.0b013e328348fc21 · Cited by 39
“…with diet) during preconception and pregnancy to mitigate the negative effects of maternal obesity include metformin, glyburides, and glucagon-like peptide analogs (Rowan et al., 2008; Dhulkotia et al., 2010; Rowan et al., 2010; Shyangdan et al., 2010; Simmons, 2010; Waugh et al., 2010).”
BackgroundSalomäki-Myftari, H., Vähätalo, L. H., Ailanen, L., Pietilä, S., Laiho, A., Hänninen, A., Pursiheimo, J.-P., Munukka, E., Rintala, A., Savontaus, E., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0163805 · Cited by 33
Diagnosis and treatment of gestational diabetes
Webb, J. (2013) · Nurse Prescribing · doi:10.12968/npre.2013.11.1.14 · Cited by 33
“glycaemic targets with treatment had the lowest risk of complications.(12) The lowest risk of complications – including birthweight greater than 4 kg, prematurity, pre-eclampsia and neonatal hypoglycaemia – occurred with fasting capillary glucose levels ≤4.”
BackgroundMa, S.-G., Yu, W., Jin, Y., Bing, H., & Hu, W. (2012) · Gynecological Endocrinology · doi:10.3109/09513590.2012.683069 · Cited by 36
Gestational Diabetes: An Update 60 Years After O’Sullivan and Mahan
McIntyre, H. D., Kampmann, U., Dalsgaard Clausen, T., Laurie, J., & Ma, R. C. W. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae709 · Cited by 32
Alqudah, A. M., McMullan, P., Todd, A., O’Doherty, C., McVey, A., McConnell, M., O’Donoghue, J., Gallagher, J., Watson, C. J., & McClements, L. (2019) · BMC Health Services Research · doi:10.1186/s12913-019-4471-9 · Cited by 32
Gatford, K. L., Houda, C. M., Lu, Z., Coat, S., Baghurst, P., Owens, J. A., Sikaris, K. A., Rowan, J., & Hague, W. M. (2013) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12080 · Cited by 32
“the effect is directly proportional to the efficacy of glucose control [6].”
BackgroundSelf-citationTherapeutic management of gestational diabetes
Jacqueminet, S., & Jannot-Lamotte, M.-F. (2010) · Diabetes & Metabolism · doi:10.1016/j.diabet.2010.11.016 · Cited by 34
Zhu, B., Zhang, L., Fan, Y., Wang, L., Li, X., Liu, T., Cao, Y., & Zhao, Z. (2016) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-016-1414-x · Cited by 28
“Many national bodies have derived their own criteria based on local experience and their healthcare delivery systems (Carpenter and Coustan Guidelines or ADIPS) [9, 27].”
Tieu, J., Coat, S., Hague, W. M., Middleton, P., & Shepherd, E. S. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007724.pub3 · Cited by 37
Self-citationRojas, J., Chávez-Castillo, M., & Bermúdez, V. (2014) · International Journal of Reproductive Medicine · doi:10.1155/2014/797681 · Cited by 27
“[161] also ascertained a decline in macrosomia and preeclampsia rates and suggested glycemic goals in GDM should be more rigorous.”
BackgroundPredictors of metformin failure in gestational diabetes mellitus (GDM)
Khin, M. O., Gates, S., & Saravanan, P. (2018) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2018.01.003 · Cited by 24
Eid, S. R., Moustafa, R. S. I., Salah, M. M., Hanafy, S. K., Aly, R. H., Mostafa, W. G., & Ghanem, A. I. M. (2018) · Egyptian Pediatric Association Gazette · doi:10.1016/j.epag.2018.01.002 · Cited by 24
Impact of different glycaemic treatment targets on pregnancy outcomes in gestational diabetes
Abell, S. K., Boyle, J. A., Earnest, A., England, P., Nankervis, A., Ranasinha, S., Soldatos, G., Wallace, E. M., Zoungas, S., & J Teede, H. (2019) · Diabetic Medicine · doi:10.1111/dme.13799 · Cited by 20
Diabetes and the Kidney in Pregnancy
Powe, C. E., & Thadhani, R. (2011) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2010.10.006 · Cited by 23
Aidenloo, N. S., Mehdizadeh, A., Valizadeh, N., Abbaszadeh, M. E., Qarequran, S., & Khalkhali, H. R. (2016) · Iranian Red Crescent Medical Journal · doi:10.5812/ircmj.31254 · Cited by 21
Preeclampsia and the risk of large-for-gestational-age infants
Powe, C. E., Ecker, J. L., Rana, S., Wang, A., Ankers, E. D., Ye, J., Levine, R. J., Karumanchi, S. A., & Thadhani, R. (2011) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2010.12.030 · Cited by 26
Is it worth treating gestational diabetes: if so, when and how?
Vääräsmäki, M. (2016) · Diabetologia · doi:10.1007/s00125-016-3976-6 · Cited by 22
“Both preprandial and postprandial glycaemia appear to be important, and lower values are often associated with lower complication rates [28].”
BackgroundPregnancy and offspring outcomes after prepregnancy bariatric surgery
Eccles‐Smith, J., Griffin, A., McIntyre, D. H., Nitert, M. D., & Barrett, H. L. (2024) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2024.08.044 · Cited by 18
Singh, N., Madhu, M., Vanamail, P., Malik, N., & Kumar, S. (2017) · The Indian Journal of Medical Research · doi:10.4103/ijmr.ijmr_1358_15 · Cited by 24
Metformin in Gestational Diabetes Mellitus
Reece, S. W., Parihar, H. S., & LoBello, C. (2014) · Diabetes Spectrum · doi:10.2337/diaspect.27.4.289 · Cited by 17
Effect of Type 2 Diabetes Mellitus on the Pharmacokinetics of Metformin in Obese Pregnant Women
Baraldi, C. D. O., Moisés, E. C. D., Carvalho, T. M. D. J. P., Antunes, N. D. J., Lanchote, V. L., Duarte, G. G., & Cavalli, R. D. C. (2012) · Clinical Pharmacokinetics · doi:10.1007/s40262-012-0008-7 · Cited by 13
“However, the patients with T2DM in the present study were young and had no impairment of renal function, as demonstrated by a median creatinine clearance of 200 mL/min, with no interference with the pharmacokinetics of metformin when compared with the patients with PCOS [35].”
Kavuran, E., & Yurttaş, A. (2018) · Iranian Red Crescent Medical Journal · doi:10.5812/ircmj.64635 · Cited by 14
Glucose Treatment Targets in Pregnancy - A Review of Evidence and Guidelines
Byford, A. R., Forbes, K. A., & SCOTT, E. M. (2022) · Current Diabetes Reviews · doi:10.2174/1573399818666220422083935 · Cited by 13
Cost-effectiveness of the New Zealand diabetes in pregnancy guideline screening recommendations
Coop, C., Edlin, R. P., Brown, J., & Farquhar, C. M. (2015) · BMJ Open · doi:10.1136/bmjopen-2014-006996 · Cited by 10
Predictors of metformin monotherapy failure in gestational diabetes mellitus
Silva, V. B., Fonseca, L., Pereira, M. T., Vilaverde, J., Pinto, C., Pichel, F., Almeida, M. D. C., & Dores, J. (2022) · Endocrine Connections · doi:10.1530/ec-21-0540 · Cited by 9
Prise en charge thérapeutique du diabète gestationnel
Jacqueminet, S., & Jannot-Lamotte, M.-F. (2010) · Journal de gynécologie, obstétrique et biologie de la reproduction. Supplément/Journal de gynécologie obstétrique et biologie de la reproduction · doi:10.1016/s0368-2315(10)70051-x · Cited by 13
“La glycémie capillaire à jeun était significativement corrélée aux complications néonatales (hypoglycémie, détresse respiratoire, photothérapie, traumatisme à la naissance, Apgar < 7 à 5 min et prématurité) et la glycémie postprandiale significativement corrélée à la prééclampsie et au poids de naissance supérieur au…”
BackgroundNew Zealand National GDM Guidelines: an alternative view of some good practice points
Rowan, J., Allen, H., Budden, A., Elder, R., Farrant, M., Hughes, R. C. E., Ivanova, V., Moore, P., Marnoch, C. A., & McGrath, N. (2015) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/ajo.12302 · Cited by 9
Self-citationClinical presentation and management of diabetes mellitus in pregnancy
Diejomaoh, M., Angelaki, E., Mohammed, A. T., & Al-Azemi, N. (2013) · International Journal of Women s Health · doi:10.2147/ijwh.s52391 · Cited by 13
Using Oral Agents to Manage Gestational Diabetes: What Have We Learned?
Buschur, E., Brown, F. M., & Wyckoff, J. (2015) · Current Diabetes Reports · doi:10.1007/s11892-014-0570-5 · Cited by 10
Comparison of Metformin with Insulin in the Management of Gestational Diabetes
Bukhari, S. M., Awan, M., & Ayoub, I. (2019) · Journal of Medicine, Physiology and Biophysics · doi:10.7176/jmpb/54-11 · Cited by 9
Preditores de sucesso da metformina no tratamento do diabetes mellitus gestacional
Silva, J. C., de Souza, B. V., & Silva, M. R. E. (2013) · Revista Brasileira de Saúde Materno Infantil · doi:10.1590/s1519-38292013000200006 · Cited by 13
“G jejum (mg/dL) X(DP) 88,17 (9,75) 98,00 (21,29) 0,01”
Metformin Opposed to Insulin in the Management of Gestational Diabetes
Borg, H. M., & Ezat, S. (2016) · Cited by 9
Pénager, C., Bardet, P., Timsit, J., & Lepercq, J. A. (2020) · Heliyon · doi:10.1016/j.heliyon.2020.e03756 · Cited by 8
“This is an open access a impact of the quality of maternal blood glucose control on the occurrence of these adverse outcomes [9, 10].”
BackgroundInfluentialGojnic, M. G., Perović, M., Pervulov, M., & Ljubić, A. (2012) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2012.672598 · Cited by 8
“If those values are not achieved by dietary regime and exercises in 2 weeks’ time, the recommendation is to introduce insulin in therapy or oral antidiabetic drugs [9,10,14].”
BackgroundMethodStorey, K. M., Shay, L. A., Poteat, T., Pennington, K. A., & Schulz, L. C. (2025) · Reproduction · doi:10.1530/rep-25-0050 · Cited by 8
Riaz, S. H., Khan, M. S., Jawa, A., Hassan, M., & Akram, J. (2018) · Pakistan Journal of Medical Sciences · doi:10.12669/pjms.342.12213 · Cited by 9
Gestational diabetes: what’s new?
Murphy, H. R. (2010) · Medicine · doi:10.1016/j.mpmed.2010.08.014 · Cited by 7
Predictors of Preeclampsia in Women in the Metformin in Gestational Diabetes(Mig) Study
Barrett, H. L. (2014) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000395 · Cited by 7
“We have also shown that glucose control on treatment is a predictor for PE, particularly post prandial glucose [18].”
BackgroundMetformin and the Development of Age-Related Macular Degeneration
Jindal, D. A., Hanna, J., Shaia, J. K., Markle, J. C., Rachitskaya, A. V., Kaelber, D. C., Singh, R. P., & Talcott, K. E. (2025) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2025.3070 · Cited by 5
Metformin versus insulin in the management of gestational diabetes mellitus
Mahmood, O. (2019) · Medical Journal of Babylon · doi:10.4103/mjbl.mjbl_11_19 · Cited by 5
“%) again the explanation is attributed to prenatal maternal hyperglycemia which cause neonatal hypoglycemia at birth result agreed by Mig TRIALS.”
BackgroundInsulin Therapy in Gestational Diabetes
Stoian, A. P., Stoica, R. A., & Ștefan, S. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.84569 · Cited by 5
Guidelines for the management of gestational diabetes in pregnancy
Glastras, S. J., & Fulcher, G. R. (2012) · Clinical Practice · doi:10.2217/cpr.12.9 · Cited by 7
A computational model of 1,5-AG dynamics during pregnancy
Zekavat, S. M., Butkovich, S. S., Young, G. J., Nathan, D. M., & Petrasek, D. (2017) · Physiological Reports · doi:10.14814/phy2.13375 · Cited by 4
Romero, J., & Spinedi, E. (2013) · Hypertension in Pregnancy · doi:10.3109/10641955.2013.807821 · Cited by 5
“stasis, GDM is usually associated with poor pregnancy outcome (3,4).”
BackgroundFarrant, M. T., Williamson, K. A., BATTIN, M. R., Hague, W. M., & Rowan, J. (2016) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/ajo.12518 · Cited by 3
Self-citationStewart, Z. A., & Murphy, H. R. (2014) · Medicine · doi:10.1016/j.mpmed.2014.10.010 · Cited by 11
Weinert, L. S., Silveiro, S. P., Salazar, C. C., Marina, B. M., Siebeneichler, A., & Reichelt, A. J. (2011) · Americanae (AECID Library) · Cited by 3
Kahouei, M., Ansariniaki, M., Homayoon, G., & Razavi, S. S. (2016) · Middle East Journal of Rehabilitation and Health Studies · doi:10.17795/mejrh-34208 · Cited by 3
Attitude and Compliance with the Onset of Insulin Therapy in Patients with Type 2 Diabetes
Davoudi, Z., Chouhdari, A., Mir, M., & Akbarian, F. (2020) · Shiraz E-Medical Journal · doi:10.5812/semj.95408 · Cited by 6
García, G. G., Campos, M. D. C., Soto, J., Diaz, A., Buchaca, E. F., Martínez, D., Bernal, M., Escobar, V., Rodríguez, L., Valdés, E., et al. (2026) · Microorganisms · doi:10.3390/microorganisms14040749 · Cited by 2
Mladenović, V., Djukić, A., Varjačić, M., & Μacut, D. (2016) · Medicinski casopis · doi:10.5937/mckg49-10238 · Cited by 3
Dememew, Z. G. (2018) · Unisa Institutional Repository (University of South Africa) · Cited by 3
Predicting macrosomic newborns using postprandial glycemia of pregnancy in diabetic women
Barros, R. A. D. J. P. A., Taborda, W., Júnior, E. A. J., Carvalho, F. H. C., Martins, M. D. G. A., Peixoto, A. B., & Bertini, A. M. (2018) · Clinical and Experimental Obstetrics & Gynecology · doi:10.12891/ceog4284.2018 · Cited by 1
Shaat, N., Akel, O., Kristensen, K. H., Nilsson, A., Berntorp, K. E., & Katsarou, A. (2024) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.14997 · Cited by 2
“In accordance with the findings of other studies, 13,30–32 the HbA1c levels measured at the first visit to specialist antenatal care were independently associated with LGA.”
InfluentialGhanei, A., Fattahi, M. A., & Banadkoki, M. G. (2024) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-024-01520-5 · Cited by 1
“This suggests that the reason for this high rate of treatment failure may be the metformin’s delayed onset of action and the variations in patient characteristics at the time of the disease’s diagnosis [28, 34 –36].”
Eficácia da metformina no tratamento do diabetes mellitus gestacional
Sales, W. B., Silva, M. R. E., do Amaral, A. R., Ferreira, B. D. S., Silva, J. C., & Bertini, A. M. (2016) · Revista Brasileira de Pesquisa em Saúde/Brazilian Journal of Health Research · doi:10.21722/rbps.v17i3.14510 · Cited by 18
Sara, J., & Alsayari, R. (2011) · InTech eBooks · doi:10.5772/23830
Metformin in gestational diabetes mellitus
Tertti, K. (2013) · UTUPub (University of Turku)
Towards defining criteria for metformin usage in management of Gestational Diabetes Mellitus.
Mahboobi, H., Khorgoei, T., & Najafian, A. (2010) · DOAJ (DOAJ: Directory of Open Access Journals)
Saedabad, A. G. A., Rezaie, R., Javadmoosavi, S. Y., Sarab, G. A., Malekaneh, M., & Houshyar, R. (2019) · Modern Care Journal · doi:10.5812/modernc.80971 · Cited by 2
A Comparative Study on Feto-Maternal Outcome of GDM Treated by Either Insulin or Metformin
Noor, T., Parvin, T., Siddika, S., Begum, F., Banu, S. A., Tasnim, S., & Jahan, P. (2020) · Bangladesh Journal of Obstetrics & Gynaecology · doi:10.3329/bjog.v34i1.56669
Current literature in diabetes
(2010) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1023
Management of Gestational Diabetes Mellitus in Middle East and North Africa: Systematic review
Dagestani, H. F., Alamri, A., Alshammari, F. B., & Alanazi, S. (2024) · Medical Science · doi:10.54905/disssi.v28i145.e20ms3312
“According to Rowan et al., (2010) postprandial glucose predicted preeclampsia and LGA newborns, fasting capillary glucose predicted neonatal complications, and HbA1c% predicted LGA infants.”
MethodJiang, L., Peng, N., Xue, M., Wei, R., Lu, G., Fan, Y., Zhang, S., Lyu, B., & Yao, D. (2026) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-026-09752-4
“In addition, most of the existing evidence is derived from randomized controlled trials (RCTs) [13, 14].”
Metadata
- Authors
- Rowan, J. A., Gao, W., Hague, W. M., & McIntyre, H. D.
- Affiliations
- Auckland City Hospital (NZ)
- Temple University (US)
- Women's and Children's Hospital (AU)
- Department of Obstetric Medicine, University of Queensland and Mater Health Services, South Brisbane, Queensland, Australia.
- Corresponding author
- Gao, Wanzhen
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2009-10-21
- Volume
- 33
- Issue
- 1
- Pages
- 9-16
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2797992
- OpenAlex
- W2114195383
- Cited by
- 96
- References
- 20
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 6 · 2022: 3 · 2021: 1 · 2020: 3 · 2019: 6 · 2018: 10 · 2017: 7 · 2016: 10 · 2015: 9 · 2014: 6 · 2013: 8 · 2012: 6
- FWCI
- 8.80
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
- Funders
- Auckland Medical Research Foundation
- Medical Research Council
- National Health and Medical Research Council
- Health Research Council of New Zealand
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- gestational diabetes mellitus, glycemic control, metformin, insulin therapy, capillary blood glucose, HbA1c, fasting blood glucose, postprandial blood glucose, neonatal complications, preeclampsia, large for gestational age, small for gestational age, maternal obesity, glycemic targets
- MeSH terms
- Birth Weight, Female, Gestational Age, Glucose Tolerance Test, Humans, Hypoglycemic Agents, Infant, Newborn, Infant, Small for Gestational Age, Insulin, Metformin, Pregnancy, Pregnancy Outcome, Diabetes, Gestational, Treatment Outcome, Diabetes Complications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.